Please assess the completion status of the following clinical trial:

Trial Title: The Effect of Sodium Thiosulfate Eardrops on Hearing Loss in Patients Who Receive Cisplatin Therapy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Adults receiving cisplatin therapy in the dose range of 80-120mg/m2~2. Subjects are capable of giving informed consent, or if appropriate, have an acceptable surrogate capable of giving consent on the subject's behalf.~Exclusion Criteria:~1. Subjects with active middle ear disease (unilateral or bilateral)~2. Subjects with prior treatment with platinum-based chemotherapeutic agent or other ototoxic agent~3. Subjects with an allergy to sodium thiosulfate~4. Subjects with tumors involving cranial nerve VIII~5. Subjects with preexisting absence of otoacoustic emissions (unilateral or bilateral)~6. Subjects with more than 5 dB interaural difference in puretone threshold on initial audiometric screening~7. Chronic use of known ototoxic agent (e.g. furosemide, aminoglycosides, etc)~8. Subjects with a history of prior irradiation to the head and neck.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Experimental Ear - Sodium Thiosulfate (STS) (Type: EXPERIMENTAL): Subjects enrolled to study will have their ears randomized for treatment with STS. The experimental ear will receive STS treatments, while the comparator ear will receive a placebo.
- Comparator Ear - Placebo (Type: PLACEBO_COMPARATOR): Subjects enrolled to study will have their ears randomized for treatment with STS. The experimental ear will receive STS treatments, while the comparator ear will receive a placebo.

Based on this trial design, predict the completion outcome and termination type (if applicable).